Clinical Trial Detail

NCT ID NCT01712659
Title Ruxolitinib for Adult T-Cell Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

adult T-cell leukemia

Therapies

Ruxolitinib

Age Groups: adult

No variant requirements are available.